As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
The Times of India on MSN1d
Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking studyA discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...
GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback